Latest Earnings Analysis
-
Mesoblast (MESO) Q2 2026: Ryonsel Launch Drives $49M Revenue as Adult Label Expansion and BLA Filings Advance
February 28, 2026 · MESO
-
HE (HE) Q4 2025: $479M Maui Settlement Nears as PBR Overhaul and CapEx Cycle Reshape Utility Trajectory
February 28, 2026 · HE
-
Grupo Televisa (TV) Q4 2025: Fiber Network to Reach 75% of Footprint as OPEX Drops 8.3%
February 28, 2026 · TV
-
Data I/O (DAIO) Q4 2025: Recurring Revenue Hits 58% as Edge AI Demand Reshapes Pipeline
February 28, 2026 · DAIO
-
Nexa (NEXA) Q4 2025: Mining EBITDA Margin Hits 50% as Aripuana Ramps, Silver Leverage Rises
February 28, 2026 · NEXA
-
Alpha Metallurgical Resources (AMR) Q4 2025: 4.1M Tons Locked at $136, Buffering Against Volatile Met Markets
February 27, 2026 · AMR
-
TransAlta (TAC) Q4 2025: Data Center MOU Unlocks 1GW Growth Path, Alberta Hedge Premiums Buffer Price Weakness
February 27, 2026 · TAC
-
Intest (INTT) Q4 2025: Backlog Jumps 36% as Non-Semi Orders Fuel Diversification
February 27, 2026 · INTT
-
Delek US (DK) Q4 2025: EOP Target Doubled to $200M, Unlocking Cash Flow and Margin Leverage
February 27, 2026 · DK
-
PubMatic (PUBM) Q4 2025: Emerging Revenue Soars 75% as Agentic AI Adoption Accelerates
February 27, 2026 · PUBM
-
MSC Income Fund (MSIF) Q4 2025: Private Loan Portfolio Climbs $57M, Sharpening Yield Focus
February 27, 2026 · MSIF
-
NHI (NHI) Q4 2025: Shop NOI Soars 125% as Platform Expands to 12% of Portfolio
February 27, 2026 · NHI
-
Goldman Sachs BDC (GSBD) Q4 2025: Software ARR Exposure Cut to 11% as AI Risk Drives Portfolio Rotation
February 27, 2026 · GSBD
-
NIQ (NIQ) Q4 2025: AI-Driven Cost Actions Unlock $65M Annual Savings, Margin Expansion Ahead
February 27, 2026 · NIQ
-
Photronics (PLAB) Q1 2026: High-End IC Revenue Climbs 19% as Capacity Expansion Accelerates
February 27, 2026 · PLAB
-
Amneal Pharmaceuticals (AMRX) Q4 2025: Specialty Segment Jumps 38% as Complex Launches Reshape Growth Mix
February 27, 2026 · AMRX
-
CubeSmart (CUBE) Q4 2025: New Supply Headwinds Drop to 19%, Unlocking Path to Revenue Growth
February 27, 2026 · CUBE
-
SHO Q4 2025: Expense Growth Held to 3% as Asset Recycling Remains Core Capital Lever
February 27, 2026 · SHO
-
Treece Medical (TMCI) Q4 2025: 25% Surgeon Uptake on New Platforms Drives Portfolio Penetration Despite 9% Revenue Drop
February 27, 2026 · TMCI
-
Main Street Capital (MAIN) Q4 2025: Lower Middle Market Investments Surge $253M, Redefining Portfolio Growth Trajectory
February 27, 2026 · MAIN
-
Concentra (CON) Q4 2025: EBITDA Margin Expands 100bps as Onsite Clinics Surge 112%
February 27, 2026 · CON
-
NRP Q4 2025: $39M Soda Ash JV Injection Delays Distribution Upside Amid Commodity Lows
February 27, 2026 · NRP
-
Docebo (DCBO) Q4 2025: Enterprise Pipeline Drives 14.5% ARR Growth Ex-AWS, Setting Up H2 Reacceleration
February 27, 2026 · DCBO
-
Buenaventura (BVN) Q4 2025: CAPEX Jumps to $415M as San Gabriel Ramp-Up Delays Bite
February 27, 2026 · BVN
-
TTEC (TTEC) Q4 2025: Digital Segment Faces $193M Impairment as AI-Driven Mix Shift Accelerates
February 27, 2026 · TTEC
-
Gogo (GOGO) Q1 2025: Service Revenue Jumps 143% as Galileo and 5G Position for Multi-Orbit Upside
February 27, 2026 · GOGO
-
Diversified Energy (DEC) Q4 2025: $277M Debt Reduction Underscores Cash Yield Model Strength
February 27, 2026 · DEC
-
Fulgent Genetics (FLGT) Q4 2025: $59M Customer Loss Offset by 53% AP Expansion and AI Leverage
February 27, 2026 · FLGT
-
Assured Guaranty (AGO) Q4 2025: Share Buybacks Reach 12% as Annuity Reinsurance Expands Revenue Base
February 27, 2026 · AGO
-
First Dibs (DIBS) Q4 2025: Adjusted EBITDA Margin Expands 1,300bps as Marketplace Model Proves Resilient
February 27, 2026 · DIBS
-
BCSF Q4 2025: Portfolio Yield Slips to 10.8% as Rate Decline Pressures Income
February 27, 2026 · BCSF
-
Amrize (AMRZ) Q4 2025: $900M CapEx Signals Aggressive Expansion as Commercial Demand Accelerates
February 27, 2026 · AMRZ
-
RLJ (RLJ) Q4 2025: Non-Room Revenue Surges 7.2%, Validating Urban-Centric ROI Strategy
February 27, 2026 · RLJ
-
DiamondRock Hospitality (DRH) Q4 2025: CapEx Reset to 7-9% of Revenue Unlocks $100M+ for Shareholder Returns
February 27, 2026 · DRH
-
Block (SQ) Q4 2025: Workforce Cut of 4,000 Sets Stage for 54% Profit Surge in 2026
February 27, 2026 · XYZ
-
Arbor Realty Trust (ABR) Q4 2025: Non-Performing Asset Resolutions Target $100M Income Recovery
February 27, 2026 · ABR
-
Pembina Pipeline (PBA) Q4 2025: Marketing EBITDA Falls 14% as Volatility Reshapes Growth Playbook
February 27, 2026 · PBA
-
Global Partners (GLP) Q4 2025: GDSO Fuel Margins Jump $0.09 as Portfolio Optimization Reshapes Earnings Mix
February 27, 2026 · GLP
-
PureCycle (PCT) Q4 2025: Denver Feedstock Ramps 44%, Unlocking Commercial Pipeline for 2026
February 27, 2026 · PCT
-
MasTec (MTZ) Q4 2025: Backlog Jumps 33% to $18B, Locking in Multi-Year Visibility
February 27, 2026 · MTZ
-
Frontline (FRO) Q4 2025: VLCC Rates Surge 44% as Tight Fleet Age Profile Drives Cash Flow Upside
February 27, 2026 · FRO
-
FIP (FIP) Q4 2025: Rail Integration Delivers 34% EBITDA Lift, Monetization and M&A in Focus
February 27, 2026 · FIP
-
ANI Pharmaceuticals (ANIP) Q4 2025: Rare Disease Revenue to Reach 60% of $1B+ Sales in 2026
February 27, 2026 · ANIP
-
Carter’s (CRI) Q4 2025: Tariff Headwind Swells to $200M, Forcing Margin Realignment
February 27, 2026 · CRI
-
Arcosa (ACA) Q4 2025: $450M Barge Sale Sharpens Focus as Utility Structures Revenue Climbs 20%
February 27, 2026 · ACA
-
BrightSpring Health (BTSG) Q4 2025: EBITDA Jumps 41% as Specialty Pharmacy and Home Health Scale
February 27, 2026 · BTSG
-
Escalade (ESCA) Q4 2025: Gross Margin Jumps 280bps as Cost Actions Reshape Profitability
February 27, 2026 · ESCA
-
Calumet (CLMT) Q4 2025: Net Leverage Falls to 4.9x as Cost Discipline Drives Durable Cash Flow
February 27, 2026 · CLMT
-
Morgan Stanley Direct Lending Fund (MSDL) Q4 2025: Distribution Cut to 45 Cents Signals Defensive Pivot Amid 40% LTV Discipline
February 27, 2026 · MSDL
-
GlobalStar (GSAT) Q4 2025: Two-Way IoT Launch Expands Addressable Market by 50%
February 27, 2026 · GSAT